AGP Picks
View all

Banking Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Banking Press Releases.

Press releases published on September 25, 2026

Diamond Equity Research Releases Update Note on Allied Critical Metals Inc. (CSE: ACM) (OTCQB: ACMIF) (FSE: 0VJ0)
Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
Cipher Digital Expands Barber Lake Lease Term to 20 Years, Increasing Revenue to Over $9 Billion
X-energy Announces Planned Retirement of TRISO-X President Joel Duling
TruGolf Announces Reverse Stock Split
Quantum Cyber Sharpens Strategic Focus to Quantum Navigation, Interceptor Drones, and U.S. Manufacturing, and Presents New Corporate Investor Presentation
Abaxx Exchange Gold Kilobar Futures Named Best Innovation by an Exchange or Clearing House at 2026 FOW Asia Pacific Awards
Ferrellgas Partners, L.P. Reports Fourth Quarter And Full Fiscal Year 2026 Results
Kaplan Fox Reminds Rackspace Technology, Inc. (NASDAQ: RXT) Investors to Protect Their Rights Before the Deadline on September 28, 2026
Cerenome to Hold CNSide® Business Update Call on September 30, 2026
GTCFX Marks a Successful Presence at Forex Expo Dubai 2026
ICODA Marketing Agency Launches Creator Program for Crypto and Web3 Projects
Edible Garden Wins Third New Walmart Fresh Herb Distribution Center Award, Accelerating Expansion Across the Eastern Midwest
Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in The Bahamas to Provide OCU400 to Patients for Treatment of Retinitis Pigmentosa
Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion
MetaOptics Ltd. Begins Trading on OTCQX Best Market
C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting
Reborn Coffee Enters into Strategic MOU with Visvita to Expand Global Franchise Supply Chain and Enter RTD Beverage Channels
FactSet Appoints Marcel Prins to Board of Directors

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Banking Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.